New pharmaceutical target reverses osteoporosis in mice: Duke researchers show that activating the adenosine receptor A2B not only halts but reverses bone deterioration in mouse models of osteoporosis

No comments

Read More About This Article: https://ift.tt/2HjsqkS

No comments :

Post a Comment